Boston-based Brigham and Women’s Hospital, a founding member of Mass General Brigham, today announced a $100 million gift from biotechnology entrepreneur Gene Lay, MS, DVM, founder and CEO of BioLegend, through the Laygend Foundation.
The gift — the largest in Brigham’s history — will establish The Gene Lay Institute of Immunology and Inflammation of Brigham and Women’s Hospital, Massachusetts General Hospital (MGH), also a founding member of Mass General Brigham, and Harvard Medical School (HMS).
Vijay Kuchroo, DVM, PhD, an immunologist and principal investigator at the Brigham, will serve as inaugural director of the institute, which will be located at and administered by Brigham. Read more.
